<SEC-DOCUMENT>0001193125-26-117682-index.html : 20260320
<SEC-HEADER>0001193125-26-117682.hdr.sgml : 20260320
<ACCEPTANCE-DATETIME>20260320161925
ACCESSION NUMBER:		0001193125-26-117682
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260320
DATE AS OF CHANGE:		20260320
EFFECTIVENESS DATE:		20260320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lantheus Holdings, Inc.
		CENTRAL INDEX KEY:			0001521036
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				352318913
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36569
		FILM NUMBER:		26778464

	BUSINESS ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
		BUSINESS PHONE:		978 671-8001

	MAIL ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lantheus MI Holdings, Inc.
		DATE OF NAME CHANGE:	20110517
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>d927762dars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: d927762dars.pdf

</DOCUMENT>
</SEC-DOCUMENT>